PharmiWeb.com - Global Pharma News & Resources

Cherry biolabs

Research & Development

Cherry biolabs was founded in 2019 as a Spin-off from the University Hospital of Würzburg with a focus on biotechnology and immunotherapy target validation. The company holds the exclusive license for the Hemibody platform technology granted by the University Würzburg.